###begin article-title 0
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Specific saposin C deficiency: CNS impairment and acid beta-glucosidase effects in the mouse
###end article-title 0
###begin p 1
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psap</italic>
###xml 295 302 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 470 474 467 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">psap</italic>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
Saposins A, B, C and D are derived from a common precursor, prosaposin (psap). The few patients with saposin C deficiency develop a Gaucher disease-like central nervous system (CNS) phenotype attributed to diminished glucosylceramide (GC) cleavage activity by acid beta-glucosidase (GCase). The in vivo effects of saposin C were examined by creating mice with selective absence of saposin C (C-/-) using a knock-in point mutation (cysteine-to-proline) in exon 11 of the psap gene. In C-/- mice, prosaposin and saposins A, B and D proteins were present at near wild-type levels, but the saposin C protein was absent. By 1 year, the C-/- mice exhibited weakness of the hind limbs and progressive ataxia. Decreased neuromotor activity and impaired hippocampal long-term potentiation were evident. Foamy storage cells were observed in dorsal root ganglion and there was progressive loss of cerebellar Purkinje cells and atrophy of cerebellar granule cells. Ultrastructural analyses revealed inclusions in axonal processes in the spinal cord, sciatic nerve and brain, but no excess of multivesicular bodies. Activated microglial cells and astrocytes were present in thalamus, brain stem, cerebellum and spinal cord, indicating regional pro-inflammatory responses. No storage cells were found in visceral organs of these mice. The absence of saposin C led to moderate increases in GC and lactosylceramide (LacCer) and their deacylated analogues. These results support the view that saposin C has multiple roles in glycosphingolipid (GSL) catabolism as well as a prominent function in CNS and axonal integrity independent of its role as an optimizer/stabilizer of GCase.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 147 148 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C1">1</xref>
###xml 293 294 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C2">2</xref>
###xml 414 415 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C3">3</xref>
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C4">4</xref>
###xml 595 596 595 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C5">5</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C6">6</xref>
###xml 808 809 808 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C7">7</xref>
###xml 921 922 921 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C8">8</xref>
###xml 923 924 923 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C9">9</xref>
###xml 953 961 953 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1104 1106 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C10">10</xref>
###xml 1109 1117 1100 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 1275 1277 1266 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C11">11</xref>
###xml 1278 1280 1269 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C12">12</xref>
###xml 1283 1290 1274 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1396 1398 1387 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C13">13</xref>
###xml 1495 1497 1486 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C14">14</xref>
###xml 426 432 <span type="species:ncbi:9606">humans</span>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
Saposin C is one of four saposins (A, B, C and D) that derive from a common precursor, prosaposin, by proteolytic processing in the late endosome (1). Each saposin is an 80 amino acid lysosomal glycoprotein with a role in enhancing the activity of specific cognate enzymes in GSL degradation (2). Saposin B presents a specific GSL, sulfatide, to its hydrolase, arylsulfatase A, for cleavage to galactosylceramide (3). In both humans and mice, saposin B deficiency results in sulfatide accumulation and a metachromatic leukodystrophy-like disease that is similar to arylsulfatase A deficiency (4,5). Saposin C interacts with GCase, leading to optimal activity (6). Biochemical studies have shown that in addition to its activation function toward GCase, saposin C protects GCase from proteolytic degradation (7). Point mutations in saposin C lead to a Gaucher-like disease due to diminished GC cleaving activity in cells (8,9). Both saposin B and C have in vitro effects on hydrolysis of LacCer by activation of galactosylceramide-beta-galactosidase, GM1-beta-galactosidase and other beta-galactosidases (10). In vitro, saposins A and C enhance GCase activity in the presence of negatively charged phospholipids, but saposin A and C have different membrane interaction modes (11,12). In vivo, saposin A and C specifically enhance the activities of galactosylcerebrosidase and GCase, respectively (13). Saposin D facilitates acid ceramidase degradation of ceramide to sphingosine and fatty acids (14).
###end p 3
###begin p 4
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C15">15</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C16">16</xref>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C17">17</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C18">18</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C19">19</xref>
###xml 423 431 423 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 436 443 436 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C20">20</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C20">20</xref>
###xml 1151 1153 1151 1153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C20">20</xref>
###xml 1154 1156 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C21">21</xref>
The structure of saposin C is restrained by three disulfide bonds (15). Biophysical studies have shown that saposin C has membrane fusion properties (16,17). This fusion occurs by the formation of intervesicular saposin C dimers as a bridge between acidic phospholipid vesicles (18). This fusogenic property is thought to be involved in the maturation of multivesicular bodies (19). Dissection of the saposin C peptide and in vitro and in vivo studies indicate regional localization of these multiple functions to specific regions of the protein, including neuritogenic activity and GCase activation (20). The fusogenic and neuritogenic activities localize to the 40 amino acids of the N-terminal, whereas the COOH-half contains the GCase activation domain (20). The former functions can be duplicated with the appropriate saposin C peptide fragments. In comparison, activation of GCase requires the COOH-half within a 'saposin' structure with intact disulfide bonds. The N-terminal 35-40 amino acid sequence is not critical to this GCase activation function, as the corresponding peptide sequence from saposin B can fulfill the overall requirements (20,21).
###end p 4
###begin p 5
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C8">8</xref>
###xml 255 256 255 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C9">9</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C22">22</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C9">9</xref>
###xml 19 24 <span type="species:ncbi:9606">human</span>
Point mutations of human saposin C present as variants of Gaucher disease. A neuronopathic (type 3) variant phenotype was associated with a C385F mutation, whereas an apparent non-neuronopathic variant occurred in the presence of an L394P substitution (8,9,22). The neuronopathic variant showed a progressive neurological deterioration and increased GC levels in the brain (9).
###end p 5
###begin p 6
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
To facilitate dissection of the physiological roles of saposin C, a mouse containing a knock-in of a cysteine-to-proline substitution in saposin C was created. The resultant saposin C-deficient mice presented with slowly developing neurological impairment that correlated with mild GSL accumulation and CNS pathology.
###end p 6
###begin title 7
RESULTS
###end title 7
###begin title 8
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Generation and verification of saposin C-deficient mice
###end title 8
###begin p 9
###xml 100 101 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F1">1</xref>
###xml 173 174 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C4">4</xref>
###xml 269 270 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F1">1</xref>
###xml 347 350 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 526 527 524 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F1">1</xref>
###xml 632 635 630 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 425 440 <span type="species:ncbi:10090">transgenic mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 965 969 <span type="species:ncbi:10090">mice</span>
The codon for the fifth cysteine of saposin C was mutated (Cys-->Pro) in the targeting vector (Fig. 1A) to destroy the disulfide bond that stabilizes the saposin C protein (4). The recombinant ES cells were screened by PCR and confirmed by Southern blot analysis (Fig. 1B). The mutation in saposin C was confirmed by DNA sequencing. To remove the neo gene in the targeting vector, heterozygous F1 mice were bred with ZP3-Cre transgenic mice. Subsequently, the Cre transgene was eliminated by crosses into WT C57BL6 mice (Fig. 1C). No differences in phenotype or histology were observed between saposin C-/- mice with or without the neo gene. Both sexes were used in the analyses, and no differences in phenotype or biochemistry were found. Mendelian ratios of saposin C-/- mice were obtained from the heterozygote crosses. Heterozygote (saposin C+/-) mice were normal phenotypically and biochemically and indistinguishable from WT. The saposin C-/- male and female mice attained the weight of WT litter mates and were fertile at maturity.
###end p 9
###begin p 10
###xml 39 40 39 40 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 378 381 376 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 423 426 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 511 514 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 523 526 521 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 533 536 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hin</italic>
###xml 545 548 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 556 559 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 566 569 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 577 580 575 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 588 591 586 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 599 602 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 622 623 620 621 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 715 718 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hin</italic>
###xml 740 743 738 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 761 762 759 760 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 869 872 867 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 491 506 <span type="species:ncbi:10090">transgenic mice</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
Targeting construct and verification. (A) Schematic map of the saposin C targeting construct. Individual saposins are encoded by the exons underlined with a dotted line. The mutation in the saposin C (Cys-->Pro) domain was in prosaposin exon 11. The point mutation destroyed one of three disulfide bridges within saposin C, which leads to a deficiency in saposin C protein. The neo gene was removed by recombination of two loxP sites by cross-breeding of saposin C heterozygotes and Zp3-Cre transgenic mice. B, BamHI; Bgl, BglII; H, HindIII; E, EcoRI; Ev, EcoRV; X, XbaI; Xho, XhoI; Nhe, NheI; Sal, SalI; *mutation site. (B) Correct targeting of ES cells was confirmed by Southern blot. The clones were digested by HindIII for 5' probe and EcoRI for 3' probe. (C) PCR genotyping of saposin C mice before and after Cre recombination using primers C-F and C-R across the loxP site.
###end p 10
###begin p 11
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F2">2</xref>
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F2">2</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 248 253 <span type="species:ncbi:10090">mouse</span>
###xml 314 319 <span type="species:ncbi:10090">mouse</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
The protein levels of prosaposin and the individual saposins in saposin C-/- mice were determined by immunoblot analyses. Saposin C protein was not detected in fibroblasts (Fig. 2A) or tissues (data not shown) from saposin C-/- mice using our anti-mouse saposin C antibody. The level of prosaposin in saposin C-/- mouse fibroblasts was slightly higher than that in WT mice detected with our anti-mouse saposin D antibody (Fig. 2B). Saposin A, B and D protein in saposin C-/- liver and cultured fibroblasts were approximately50-70% of WT levels.
###end p 11
###begin p 12
###xml 29 30 29 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 202 203 202 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
###xml 254 259 <span type="species:ncbi:10090">mouse</span>
Saposin protein expression. (A) Saposin C was not detected in the fibroblasts using anti-mouse saposin C antibody. Saposin A and B were detected by anti-mouse saposin A and B antibodies, respectively. (B) Prosaposin and saposin D were detected with anti-mouse saposin D antibody. Prosaposin levels in saposin C-/- fibroblasts were slightly increased compared to the WT control. beta-Actin was used as a loading control.
###end p 12
###begin title 13
Phenotype and neurobehavioral assessments
###end title 13
###begin p 14
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F3">3</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
Saposin C-/- mice slowly developed neurological impairment and lived up to 24 months. The onset of neurological deficits began at 10-12 months with progressive wobbling, lack of coordination, hind limb weakness and abnormal leg reflexes (Fig. 3). Ataxia developed after 12 months. No differences in phenotype were observed between males and females.
###end p 14
###begin p 15
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
###xml 188 193 <span type="species:ncbi:10090">mouse</span>
Phenotype of saposin C-/- mice at 16 months. (Left) Saposin C-/- mouse showing hind paw spreading suggesting paralysis. (Right) Saposin C-/- mouse with abnormal hindleg positioning and WT mouse with a normal V shape position in tail-hanging reflex.
###end p 15
###begin p 16
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F4">4</xref>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F4">4</xref>
###xml 998 999 998 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F4">4</xref>
###xml 1112 1113 1112 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F4">4</xref>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 843 847 <span type="species:ncbi:10090">mice</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 1088 1092 <span type="species:ncbi:10090">mice</span>
###xml 1101 1105 <span type="species:ncbi:10090">mice</span>
Neurobehavioral studies were conducted at 9 and 13 months in male saposin C-/- mice. On the narrow bridges test, saposin C-/- mice exhibited significant increases in latency and foot slips on round (11, 17 and 28 mm) (Fig. 4A) and square (12 and 25 mm) (data not shown) beams relative to WT mice. All saposin C-/- mice failed to cross the 5 mm square beam, whereas WT mice had no difficulty traversing the bridge (data not shown). Saposin C-/- mice showed increases in latency and number of slips with age. The elevated zero-maze tests for anxiety and fearfulness. Saposin C-/- mice spent longer times in open areas than WT control mice and concurrently had fewer open area entries (Fig. 4B), suggesting a decrease in anxiety-like behavior. Spontaneous locomotion testing measures exploratory and motor functions. Compared with age-matched WT mice, saposin C-/- mice showed greater vertical activity (rears) within the 60 min of testing, further suggesting a reduction of exploratory anxiety (Fig. 4C). Horizontal activity (total distance) was not significantly different in saposin C-/- mice from WT mice (Fig. 4C). These results indicate that deficiency of saposin C affects movement, coordination, anxiety behaviors.
###end p 16
###begin p 17
###xml 29 30 29 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 348 349 348 349 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 460 461 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 668 669 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 789 790 789 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 803 804 801 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 818 819 814 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 835 836 829 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 857 858 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 759 763 <span type="species:ncbi:10090">mice</span>
Neurobehavioral assessment. (A) Narrow bridges test. WT and saposin C-/- mice were tested on 11, 17 and 28 mm round beams at 9 and 13 months. Saposin C-/- mice showed significant increases of latency (left) across the beam and foot slips (right) compared with WT. Latency and number of slips in saposin C-/- mice progressively increased with age. (B) Zero-maze test. Relative to WT, saposin C-/- mice had fewer entries and spent longer time in the open area. (C) Locomotor activity. (Left) Saposin C-/- mice exhibited significantly enhanced vertical activity (P < 0.02) compared with WT. (Right) Total distance activity in saposin C-/- mice was not different from WT (P < 0.1). Activity was recorded every 5 min over a 60-min period. WT and saposin C-/- male mice were used in the tests. *P </= 0.05; **P </= 0.01; ***P </= 0.001. WT, n = 16; saposin C-/-, n = 21.
###end p 17
###begin p 18
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F5">5</xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
Long-term potentiation (LTP) was measured in the hippocampus at 4 and 24 months Compared with WT mice, saposin C-/- mice showed significantly reduced LTP at 24 months (Fig. 5), suggesting deficiency of saposin C altered hippocampal plasticity, a cellular marker associated with learning and memory. No significant difference in LTP was observed in the mice at 4 months (data not shown).
###end p 18
###begin p 19
###xml 338 339 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 432 433 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 458 459 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
Electrophysiology analysis of long-term potentiation (LTP). The fEPSPs were recorded from parasagittal sections (350 microm) of hippocampal CA1 region using the MED64 multielectrode array system to determine the slope of resulting EPSPs. The slopes of the EPSPs (LTP) in 24-month-old saposin C-/- mice (closed circle) were significantly (P < 0.05) decreased compared with WT mice (open circle) for 90 min following stimulation. WT, n = 7 mice; saposin C-/-, n = 6 mice.
###end p 19
###begin title 20
Histopathological analyses
###end title 20
###begin p 21
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F6">6</xref>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F6">6</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C23">23</xref>
###xml 832 833 832 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F6">6</xref>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 667 671 <span type="species:ncbi:10090">mice</span>
###xml 689 693 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 1212 1216 <span type="species:ncbi:10090">mice</span>
###xml 1250 1254 <span type="species:ncbi:10090">mice</span>
Saposin C-/- mice had foamy storage material in the dorsal root ganglion starting at 25 weeks. Larger axonal spheroids were evident in the dorsal horn of the spinal cord (Fig. 6A). No storage cells were visible in the brain. Pro-inflammation in saposin C-/- mice was assessed using anti-CD68 and anti-GFAP antibody staining (Fig. 6B). CD68 is an intracellular membrane glycoprotein that is expressed in quiescent and activated tissue macrophages (23). GFAP is an astrocytic marker. The enhanced GFAP signals indicate astrogliosis. Clearly enhanced CD68 and GFAP signals were found in spinal cord, brainstem, hindbrain, cerebellum and thalamic regions in saposin C-/- mice compared with WT mice. Disease progression was evident in H&E stained paraffin sections of spinal cord and cerebellum in 3-19-month-old saposin C-/- mice (Fig. 6C). Axonal spheroids were present in spinal cord dorsal horn after 6 months, but absent at 3 months. The Purkinje cell layer in cerebellar lobule IV was normal at 3 months. Loss of Purkinje cells was observed after 6 months. TUNEL assays of paraffin sections were negative suggesting that loss of Purkinje cells was not by an apoptotic mechanism. Visceral organs in saposin C-/- mice were not distinguishable from WT mice.
###end p 21
###begin p 22
###xml 29 30 29 30 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 466 467 466 467 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 568 570 568 570 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B1</bold>
###xml 589 591 589 591 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2</bold>
###xml 623 625 623 625 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B3</bold>
###xml 979 980 979 980 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 918 922 <span type="species:ncbi:10090">mice</span>
###xml 1060 1064 <span type="species:ncbi:10090">mice</span>
CNS pathology in C-/- mice. (A) The paraffin sections of dorsal root ganglion and dorsal horn of spinal cord from 15-month-old saposin C+/- or C-/- mice were stained with H&E. Foamy storage material (arrows) was present in the dorsal root ganglion neurons of saposin C-/- mice. Larger axonal spheroids (arrows) were present in the spinal cord dorsal horn of these mice. As a control, saposin C+/- mice had normal morphology in dorsal root ganglion and spinal cord. (B) CNS proinflammation in saposin C-/- mice demonstrated by anti-GFAP (B1-B3) and anti-CD68 (B4-B6). (B1) WT spinal cord, (B2) saposin C-/- spinal cord and (B3) C-/- midbrain at 15 months showed astrogliosis with enhanced GFAP (green) signal. The nucleus was labeled by DAPI (blue). (B4) C-/- dorsal horn of spinal cord. (B5) C-/- thalamus. (B6) C-/- brain stem. Microglial cells were stained by anti-CD68 antibody (brown) in 24-month-old saposin C-/- mice. Tissue sections were counterstained with hematoxylin. (C) H&E stained paraffin sections of spinal cord and cerebellum from saposin C-/- mice at 3, 6, 12 and 18 months. Axonal spheroids were present in dorsal horn of spinal cord at 6, 12 and 18 months, but absent at 3 months. Purkinje cell layer (arrows) in cerebella lobule IV was normal at 3 months. Loss of Purkinje cells (*) was evident at 6 months and older.
###end p 22
###begin p 23
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F7">7</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F7">7</xref>
###xml 568 569 568 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F7">7</xref>
###xml 710 711 710 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F7">7</xref>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F7">7</xref>
###xml 437 441 <span type="species:ncbi:10090">mice</span>
Loss of Purkinje cells in the cerebellum was evident at 2 months and progressed chronologically from lobule III to X, demonstrated by anti-calbindin antibody staining (Fig. 7A), such that by 24 months Purkinje cells were absent in lobules III to VIII. Calbindin staining revealed the degeneration of Purkinje cell axons in molecular layers and the appearance of spheroids in neuronal processes in cerebellar white matter of saposin C-/- mice (Fig. 7B). In addition, granule cell atrophy was demonstrated by decreased NeuN-stained cells in the granule cell layer (Fig. 7D). The Purkinje cell loss was subsequent to granule cell atrophy. Cerebellar reduction in C-/- was particularly evident at >20 months (Fig. 7A and C). In the same regions, increases in astrogliosis and activated microglial cells were evident (Fig. 7D).
###end p 23
###begin p 24
###xml 26 27 26 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 435 436 435 436 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 554 556 554 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B1</bold>
###xml 615 617 615 617 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2</bold>
###xml 737 739 737 739 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B3</bold>
###xml 793 795 793 795 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B4</bold>
###xml 875 876 875 876 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1032 1033 1032 1033 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 607 612 <span type="species:ncbi:10090">mouse</span>
###xml 729 734 <span type="species:ncbi:10090">mouse</span>
###xml 867 872 <span type="species:ncbi:10090">mouse</span>
###xml 905 910 <span type="species:ncbi:10090">mouse</span>
###xml 1085 1089 <span type="species:ncbi:10090">mice</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
###xml 1244 1249 <span type="species:ncbi:10090">mouse</span>
###xml 1415 1420 <span type="species:ncbi:10090">mouse</span>
Pathology in cerebellum. (A) Anti-calbindin antibody stained Purkinje cells (brown) in 24-month-old C+/- and C-/- mouse brain. Loss of Purkinje cells in saposin C-/- mice progressed from cerebella lobule III to X with age. Increases of astrogliosis demonstrated by anti-GFAP antibody staining (brown) were in the region where the Purkinje cells were lost. Normal Purkinje cell layers and astrocytes were found in the C+/- cerebellum. (B) Calbindin staining revealed axon and neuronal processes in the molecular layer and white matter of the cerebellum. (B1) Normal Purkinje cells and axons (arrows) in C+/- mouse. (B2) Degeneration of Purkinje cell axons (stars) in the molecular layer of cerebella lobule X in 24-month-old C-/- mouse. (B3) Neuronal processes in C+/- cerebella white matter. (B4) Neural spheroids (arrows) presented in the neuronal processes of C-/- mouse. (C) 24-month-old C+/- and C-/- mouse cerebellum. The white bars show the height of cerebellum. The size of saposin C-/- cerebellum was reduced at 24 months. (D) Atrophy in the granule cell layer of saposin C-/- mice. NeuN staining cells (green) were decreased in the granulecell layer of cerebella lobule III from 24-month-old C-/- mice compared with lobule III of C+/- mouse. The white bar in the photo shows the diameter of the granule cell layer. Both GFAP (brown) and CD68 (brown) signals were enhanced in lobule III of the saposin C-/- mouse. Sections stained with calbindin and GFAP were counterstained with methyl green (green). CD68-stained sections were counterstained with hemotoxilin.
###end p 24
###begin p 25
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F8">8</xref>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F8">8</xref>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
Ultrastructural analyses revealed that axonal and neuronal processes contained electron-dense complex membrane whirl inclusions in saposin C-/- mice at 18 months (Fig. 8). The storage inclusion materials are heterogeneous and membrane bound bodies. The inclusion bodies were found in spinal cord, brainstem, midbrain, cortex, hippocampus, cerebellum and sciatic nerve. The sciatic nerve exhibited inclusion bodies and degenerating myelin layers. More neuronal processes containing inclusions were observed at 18 or 22 months than that at 10 months. No inclusions or excesses of multivesicular bodies were found in cerebral neurons or Purkinje cells at 10, 18 and 22 months (Fig. 8).
###end p 25
###begin p 26
###xml 26 27 26 27 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 103 104 103 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 211 212 211 212 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 257 258 257 258 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 334 335 334 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 427 428 427 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 504 505 504 505 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 638 639 638 639 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 461 466 <span type="species:ncbi:10090">mouse</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 707 711 <span type="species:ncbi:10090">mice</span>
Ultrastructural studies. (A) The spinal cord of saposin C+/- mice at 18 months had normal morphology. (B) The spinal cord of saposin C-/- mice at 18 months showed inclusion bodies (arrows) in neuronal process. (C) Enlarged view of inclusion bodies in (B). (D) Cortical neuron in saposin C-/- mice at 10 months had normal morphology. (E) Axonal inclusions (arrow) in granule cell layer of saposin C-/- cerebellum at 18 months. (F) Purkinje cells in saposin C-/- mouse at 10 months had normal morphology. (G) The sciatic nerve of saposin C-/- mice at 18 months had inclusion materials (arrows) and degenerating myelin layers (arrowheads). (H) Axonal inclusion material (arrow) in the midbrain of saposin C-/- mice at 18 months.
###end p 26
###begin title 27
Biochemical analysis
###end title 27
###begin p 28
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F9">9</xref>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F9">9</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F9">9</xref>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 644 648 <span type="species:ncbi:10090">mice</span>
GSLs in 13-month-old saposin C-/- mice showed increases in spinal cord GC (1.4-fold) and GS (1.3-fold) compared with WT mice (Fig. 9A and B). The LacCer levels (Fig. 9C) in the spinal cord were unchanged, but LacSph (Fig. 9D) was 2.3-fold higher than in the WT controls. In the cerebellum, the GC and GS of saposin C-/- mice were at WT levels at 13 months. Both LacCer and LacSph accumulated in the saposin C-/- mouse cerebellum to 1.9- and 1.6- fold of WT levels, respectively. No significant changes of ceramides and hydroxy ceramides were found in the cerebellum or spinal cord. The cerebral cortex, midbrain, liver and lung of saposin C-/- mice had no significant alteration of GSLs relative to the WT control.
###end p 28
###begin p 29
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 372 373 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 389 390 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
GSL analyses. Spinal cord and cerebellum lysate were analyzed for GC, GS, LacCer and LacSph. Saposin C-/- mice had significant increases of GC, GS and LacSph in the spinal cord. LacCer and LacSph increased in the C-/- cerebellum. The amounts of lipids were normalized to phosphate in each sample. Age-matched 13-month-old WT and C-/- mice were used in the assay (n = 3). *P </= 0.05 and **P </= 0.01.
###end p 29
###begin p 30
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C24">24</xref>
###xml 218 220 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F10">10</xref>
###xml 295 297 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DDP531F10">10</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 405 409 <span type="species:ncbi:10090">mice</span>
GCase activity in tissues was assayed with 4MUG as substrate (24). In comparison to WT mice, saposin C -/- mice at 2 months showed decreases in GCase activity by approximately50% in liver, lung, spleen and brain (Fig. 10A). GCase protein levels in saposin C-/- liver were 67% of WT levels (Fig. 10B). GCase activity and protein level in heterozygote (saposin C+/-) mice were not different from that in WT mice.
###end p 30
###begin p 31
###xml 42 43 42 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 167 168 155 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 302 303 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
GCase activity and protein in C-/- mice. (A) GCase activity levels were decreased in C-/- liver, lung, brain and spleen by approximately50% relative to the WT level. (B) The GCase protein level in the C-/- liver was 67% of the WT level. Age-matched 2-month-old WT and C-/- mice were used in the assay (n = 3).
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 41 48 41 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1638 1639 1638 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C7">7</xref>
###xml 2155 2157 2155 2157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C25">25</xref>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 233 238 <span type="species:ncbi:10090">mouse</span>
###xml 1915 1919 <span type="species:ncbi:10090">mice</span>
###xml 2141 2146 <span type="species:ncbi:10090">mouse</span>
###xml 2208 2212 <span type="species:ncbi:10090">mice</span>
To understand the functions of saposin C in vivo, a saposin C-deficient mouse was created in the presence of near-normal amounts of saposins A, B and D that are derived from prosaposin. The primary manifestations in the saposin C-/- mouse were of neurodegeneration that was slow in onset and slow to progress. Within the CNS, the spinal cord and cerebellum were the primary organs involved and in particular showed axonal ballooning, neuronal loss and axonal deterioration, particularly in the spinal cord. In the cerebellum, granule cell loss was followed by Purkinje cell loss that progressed from lobules III to X, with resultant decreases in cerebellar size. Within the cerebellum, astrogliosis and some infiltration by CD68+ microglial cells indicated a significant pro-inflammatory reaction. Importantly, at both the light microscopic and the ultrastructural levels, the cerebral cortical neurons and hippocampal neurons were unchanged compared with saposin C+/- littermates, yet hippocampal LTP in Schaefer collaterals was severely reduced. Biochemically, minor storage of GC and GS was present in the spinal cord, and some increases in LacCer and LacSph were present in the cerebellum, with minor changes in LacSph in the spinal cord. No histological storage was evident in visceral tissues, and the levels of GSL in the visceral tissues were normal. The deficiency of saposin C as well as the resultant histological and biochemical changes in the CNS and in the viscera, were accompanied by decreases in GCase activity and protein, thus verifying the effect of saposin C as a proteolytic protector for GCase within the lysosome (7). These findings provide insight into the functions of saposin C independent of its function in the degradation of GC, and highlight potential previously unrecognized functions related to LacSph. Because of the ultrastructural inclusions evident in axons of the saposin C-/- mice, the current findings indicate cellular effects on axonal transport and secondary retrograde neuronal degeneration. Interestingly, the previously observed increase in multivesicular body formation in prosaposin-deficient mouse models (25) was not seen in the isolated saposin C-deficient mice described here.
###end p 33
###begin p 34
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C12">12</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C7">7</xref>
###xml 754 759 754 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
The data presented demonstrate that saposin C is a non-essential enhancer for GC degradation in vivo at the levels produced in these mice in vivo, i.e. GCase residual activity is present, whereas with an essential activator, a total deficiency of GCase function would exist. The total absence of GCase is incompatible with extra uterine survival in the mouse. However, saposin C optimizes the hydrolysis of GC by GCase (12), and probably also of GS. Importantly, saposin C is a stabilizer of GCase in lysosomes, protecting it from proteolytic digestion (7). When saposin C is absent in the presence of a detrimental mutation in GCase, the activity of GCase drops below a threshold level and enhances the accumulation of GC and GS in various tissues (Sun et al., in review). Thus, saposin C appears to be an optimizer of GCase activity: it interacts with GCase, whether mutant or WT, and protects these enzymes against proteolytic digestion by lysosomal proteases.
###end p 34
###begin p 35
###xml 171 178 171 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 194 202 194 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C26">26</xref>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C10">10</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C27">27</xref>
###xml 724 726 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C28">28</xref>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
Although total deficiency did not lead to massive increases in GC or GS in all tissues, excluding the spinal cord, saposin C could facilitate the hydrolysis of other GSLs in vivo. Specifically, in vitro saposin C is involved in the metabolism of LacCer and ceramide (26). Also, both saposin C and B enhance the degradation of LacCer (10). The unchanged levels of LacCer in the saposin C deficient mice in the visceral tissues, cerebral cortex and spinal cord, were not unexpected since saposin B can compensate for the deficiency of saposin C. In addition, the normal levels of ceramide in the saposin C deficient mice indicate a compensatory effect of saposins D and C in the degradation of ceramide by acid ceramidase (27,28).
###end p 35
###begin p 36
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C29">29</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C31">31</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C32">32</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C34">34</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C35">35</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C36">36</xref>
###xml 837 839 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C37">37</xref>
###xml 1325 1327 1325 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C36">36</xref>
###xml 1328 1330 1328 1330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C41">41</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 1104 1108 <span type="species:ncbi:10090">mice</span>
Of interest were the significant increases in LacCer and LacSph in the cerebellum of the saposin C deficient mice. Such accumulations, particularly of LacCer, were also found in prosaposin deficiency and in Niemann-Pick C mice (29-31). LacCer is a bioactive lipid that has been shown to participate in osteoclastogenesis, angiogenesis and neural inflammation (32-34). The biological activities of LacSph have not been well studied, but in analogy to other lysophinoglipids, GS and galactosylsphingosine, this lysolipid probably has significant toxicity to sensitive tissues, including neurons. Indeed, LacSph mobilizes calcium in isolated brain microsomes (35), suggesting its participation in a pathway that could lead to neuropathological consequences and neuronal inflammation. Similar to several other lysosomal storage diseases (36,37), saposin C deficient mice showed sensitivity of Purkinje cells to the disease state. Why this should be true for Purkinje cells, and secondarily granule cells that show specific degeneration in particular lysosomal storage diseases and in the saposin C deficient mice, is unknown, but this sensitivity has now been observed in several models, including saposin D, Niemann-Pick C, Niemann-Pick A, Chediak-Higashi syndrome, neuronal ceroid lipofucinoses and lysosomal acid phosphatase (36-41), indicating vulnerability of these cells to metabolic abnormalities including GSL.
###end p 36
###begin p 37
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C42">42</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C43">43</xref>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C42">42</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C44">44</xref>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 33 39 <span type="species:ncbi:9606">humans</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
In prosaposin-deficient mice and humans, fibroblasts and other tissues have been shown to have increased numbers of multivesicular bodies (42,43). This has led to the suggestion that prosaposin and its function in GSL metabolism may be critical to the formation of multivesicular bodies, endosomes and lysosomes (42,44). However, in the CNS of the saposin C deficient mice no increase in multivesicular bodies was observed by EM studies. These studies were applied to both cortical neurons and the Purkinje cells. Consequently, multivesicular bodies formation does not appear to be a mechanism involved in pathologic degeneration in the cortex, cerebellum or spinal cord. Cell death caused by apoptosis was unlikely in these mice as suggested by negative TUNEL assay. However, saposin C may have additional functions in cellular metabolism beyond that for the degradation of GSLs, particularly GC, GS, LacCer and LacSph. As is evident in the spinal cord, retrograde axonal degeneration was present as evidenced by the large deposits in the dorsal horn of the spinal cord. This correlated with the presence of inclusion bodies within the axons and suggests a mechanism of retrograde degeneration caused by saposin C deficiency. The precise role in this transport process and potential release at synapses remains to be elucidated, but it seems to be fundamental to the pathological processes within the CNS.
###end p 37
###begin p 38
###xml 477 478 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 527 529 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C45">45</xref>
###xml 530 532 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C48">48</xref>
###xml 665 667 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C48">48</xref>
###xml 866 868 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C49">49</xref>
###xml 869 871 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C50">50</xref>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
The clinical and pathological phenotype presented in saposin C-/- mice was primarily related to neuronal dysfunction. Massive Purkinje cell death occurred in cerebellum. The spheroids that contained inclusion bodies were found in axons. These pathological defects correlated with the phenotype of ataxia and decreased coordination in saposin C-/- mice. Axonal spheroids have been noted in several lysosomal storage diseases, including Niemann-Pick C, GM2 gangliosidoses, alpha-N-acetylgalactosaminidase and alpha-mannosidosis (45-48). Early findings on these lysosomal disease animal models suggest that the loss of Purkinje cells is secondary to axonal dystrophy (48). The axonal dystrophy may affect anterograde or retrograde transport, which can cause axonal degeneration and cell death, as suggested in Alzheimer's disease and other neurodegenerative disorders (49,50). Deterioration of neuromotor function and impaired hippocampal LTP could be the result of such axonal dysfunction. Saposin C is a lysosomal protein, and lysosomes in the neuron are located in the soma. Further studies will be required to define how the deficiency of saposin C leads to axonal spheroids.
###end p 38
###begin title 39
MATERIALS AND METHODS
###end title 39
###begin title 40
Materials
###end title 40
###begin p 41
###xml 590 591 587 588 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 510 514 <span type="species:ncbi:9925">goat</span>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
Reagents from commercial sources: anti-fade/DAPI, methyl green, ABC Vectastain and alkaline phosphatase kit II (Black) (Vector Laboratory, Burlingame, CA), DIG Easy Hyb, anti-digoxigenin-AP, CDP-Star, positively charged nylon membranes and Lumi-film chemiluminescent detection film (Roche Applied Science, Indianapolis, IN), Qiagen Quick-change II XL kit (Qiagen, Inc., Valencia, CA), restriction enzymes (New England Labs, Beverly, MA), NuPAGE 4-12% Bis-Tris gel, NuPAGE MES SDS running buffer, AlexaFluor488 goat anti-mouse IgG (H+L) (Invitrogen, Carlsbad, CA), 4-methylumbelliferyl-beta-d-glucopyranoside (4MUG, Sigma), M-PER Mammalian Protein Extraction Reagent and BCA protein assay reagent (Pierce, Rockford, IL) and Hybondtrade mark-ECLtrade mark nitrocellulose membrane and ECL detection reagent (Amersham Biosciences, Piscataway, NJ).
###end p 41
###begin title 42
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Construction of targeting vector and generation of saposin C-/-mice
###end title 42
###begin p 43
###xml 320 321 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C4">4</xref>
###xml 322 324 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C28">28</xref>
###xml 325 327 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C38">38</xref>
###xml 328 330 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C51">51</xref>
###xml 583 590 581 588 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCC GGG</underline>
###xml 642 649 640 647 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCC GGG</underline>
###xml 738 741 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 744 747 742 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 997 1000 995 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 1003 1006 1001 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 1079 1082 1075 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 1085 1088 1081 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 1241 1244 1237 1240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 1266 1269 1262 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 1354 1357 1350 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PGK</italic>
###xml 1369 1371 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C30">30</xref>
###xml 1445 1448 1441 1444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 1450 1453 1446 1449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 1479 1482 1475 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 1559 1562 1555 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nhe</italic>
###xml 1564 1567 1560 1563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 1591 1594 1587 1590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 1762 1765 1758 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 337 342 <span type="species:ncbi:10090">mouse</span>
###xml 441 447 <span type="species:ncbi:8164">Suzuki</span>
###xml 842 847 <span type="species:ncbi:10090">mouse</span>
Saposin C-deficient mice were created by knocking in a codon change to create the substitution cysteine-to-proline (C-->P) substitution in saposin C. This mutation eliminates one of this protein's three disulfide bridges and results in a selective deficiency in this saposin. The same strategy has been used previously (4,28,38,51). The mouse prosaposin genomic DNA clones and targeting vector (OSdupdel) were kindly provided by Dr Kunihiko Suzuki. The knock-in saposin C was created using a Qiagen Quick-change II XL kit with mismatched oligonucleotide primers: C5F (5'-AGC TCT CTG CCC GGG GTG ATC GGC CTC TG-3'), C5R (5'-CA GAG GCC GAT CAC CCC GGG CAG AGA GCT-3'). The mismatched nucleotides are underlined. The short arm of the 1.2 kb Nhe I-Xho I fragment was generated by PCR using a pBluescript subclone 7-9 containing exons 8-15 of the mouse prosaposin gene as a template. The resultant product was cloned into the TopoTA (PCR II) vector. Using the same subclone 7-9, the long arm of 4.2 kb Sal I-Xba I fragments encoding Cys-->Pro was generated by PCR and cloned into the Sal I/Xba I sites of the TA cloning vector. The OSdupdel vector contains polymer enhancer/herpes simplex virus thymidine kinase (MC1) promoter with the neomycin (neo) gene flanked by two loxP sites and the thymidine kinase (TK) gene driven by the 3' phosphoglycerate kinase (PGK) promoter (30). The long arm (4.2 kb) carrying the requisite mutation was ligated into SalI/XbaI sites downstream of MC1-neo and formed the 3' homologous region. The short arm (1.2 kb) was cloned into NheI/XhoI sites upstream of MC1-neo in the vector and formed the 5' homologous region. The sequences of long arm and short arm were confirmed by direct sequencing. The targeting vector was linearized by Not1 and introduced into a 129/SvEv ES cell line.
###end p 43
###begin p 44
###xml 285 288 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 623 626 619 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hin</italic>
###xml 634 637 630 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 702 704 698 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C28">28</xref>
###xml 737 740 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hin</italic>
###xml 836 839 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 1285 1288 1281 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 1418 1420 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C52">52</xref>
###xml 1436 1438 1432 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C28">28</xref>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1219 1224 <span type="species:ncbi:10090">Mouse</span>
###xml 1315 1319 <span type="species:ncbi:10090">mice</span>
###xml 1346 1350 <span type="species:ncbi:10090">mice</span>
###xml 1508 1512 <span type="species:ncbi:10090">mice</span>
###xml 1680 1688 <span type="species:ncbi:9606">Children</span>
PCR analysis was conducted to screen the recombinant ES clones using the primers flanking outside of the short arm: C-ES F1-25 (5'-GGTAGCATTGCATGTCTTAGCGCTG-3') and inside of the short arm: C-ES F5 (5'-GAGTGGGTCTGTTCTGAACATTGCTT-3'), in combination with the primer in the 5' region of neo, NEO2R (5'-AAC CAC ACT GCT CGA CAT TGG GTG-3'). The recombinant clones generated 1.6 kb and the wild-type (WT) clones had 1.4 kb PCR products, respectively. The recombinant ES clones were further confirmed by Southern blot analysis. Identified recombinant ES cells were amplified and DNA (10 microg) from each clone was digested with HindIII or EcoRI. Southern blots were probed with DIG labeled 5' or 3' probes (28). In the recombinant ES clones, HindIII digestion generated 8.3 kb WT and 9.5 kb recombinant fragments, identified by 5'-probe and EcoRI digestion, and resulted in 9.2 kb WT and 8.3 kb recombinant fragments with the 3'-probe. The mutations in the recombinant clones were verified by PCR and sequencing. Correctly targeted clones were used to generate chimeric mice by microinjection into C57BL/6J blastocysts. Electroporation, ES cell culture, selection and chimera breeding were carried out by the Gene-Targeting Mouse Service Core at the University of Cincinnati. To remove the neo gene, the heterozygous F1 mice were crossed into Zp3-Cre mice (C57BL/6-TgN(Zp3-Cre)93Knw purchased from The Jackson Laboratory) (52) as described (28). The strain of background for saposin C-/- is C57BL/6J/129SvEV. All mice were maintained in micro-isolators, with the exception of those going through behavior, in accordance with institutional guidelines under IACUC approval at Cincinnati Children's Research Foundation.
###end p 44
###begin title 45
PCR genotyping
###end title 45
###begin p 46
###xml 175 178 175 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lox</italic>
###xml 388 391 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 415 418 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neo</italic>
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
PCR reaction was conducted for routine mouse colony genotyping using the genomic DNA from clipped tails. After validation by sequencing of the mutations within saposin C, the loxP site was used as a marker for the point mutation genotyping with the primers C loxP F (5'-CAGATACCCCATCCTCCCATGG-3') and C loxP R (5'-TGTGAAGGACAAGAGGAGAGTG-3'). The PCR product of WT was 200 bp, mutant with neo was 1.4 kb and without neo was 307 bp.
###end p 46
###begin title 47
Histological studies
###end title 47
###begin p 48
###xml 12 13 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1273 1275 1273 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C53">53</xref>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 267 272 <span type="species:ncbi:10090">mouse</span>
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
###xml 402 406 <span type="species:ncbi:9925">goat</span>
###xml 732 737 <span type="species:ncbi:10090">mouse</span>
###xml 793 798 <span type="species:ncbi:10090">mouse</span>
###xml 887 891 <span type="species:ncbi:9925">goat</span>
###xml 939 943 <span type="species:ncbi:9925">goat</span>
###xml 949 954 <span type="species:ncbi:10090">mouse</span>
Following CO2 narcosis, mice were perfused with saline and then 4% paraformaldehyde. The tissues were dissected and fixed in 10% formalin, embedded in paraffin, sectioned and stained with hemotoxilin and eosin (H&E). Paraffin sections of cerebellum were stained with mouse anti-calbindin D28K (Sigma, C9848) and mouse anti-GFAP (Sigma, G3893). The antibodies were diluted 1/500 or 1/200 in PBS with 3% goat serum and 0.2% Triton X-100, respectively. Detection was with ABC Vectastain and the alkaline phosphatase kit II (Black), according to the manufacturer's instructions. The slides were counterstained with methyl green. For immunofluorescence staining, frozen sections from 4% paraformaldhyde fixed tissues were incubated with mouse anti-GFAP (1/200). Paraffin sections were reacted with mouse anti-NeuN (1/100) (Chemicon, MAB377). The antibodies were diluted in PBS with 3% normal goat serum and 0.2% Triton X-100. Both biotinylated goat anti-mouse and streptavidin-conjugated fluorescent 480 (green) were applied to the sections. The samples were counterstained with antifade/DAPI. The signals were visualized with a Zeiss Axiovert 200M microscope equipped with an Apotome. CD68 monoclonal antibody (Serotec, FA-11) staining on the frozen sections was as described (53). Karnovsky's fixative was used for ultrastructural studies.
###end p 48
###begin title 49
Immunoblot
###end title 49
###begin p 50
###xml 479 481 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C28">28</xref>
###xml 350 356 <span type="species:ncbi:9986">rabbit</span>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
###xml 484 489 <span type="species:ncbi:10090">Mouse</span>
Tissues or cell extracts (50-200 microg) were prepared in M-PER (Mammalian Protein Extraction Reagent) and separated on NuPAGE 4-12% Bis-Tris gel with NuPAGE MES SDS running buffer, and electro-blotted on Hybondtrade mark-ECLtrade mark nitrocellulose membranes. The membranes were blocked in 3% BSA for 1 h, followed by incubation overnight with the rabbit anti-mouse saposin D, C, A or B antibodies (1/500 in 0.15% milk and 1% BSA) to detect individual saposins and prosaposin (28). Mouse anti beta-actin monoclonal antibody (1/10 000 in 2% w/v dry milk) was applied to detect beta-actin. The signal was developed using ECL detection reagent according to the manufacturer's instructions. Protein concentration was determined using BCA protein assay reagent.
###end p 50
###begin title 51
GCase activity and protein
###end title 51
###begin p 52
###xml 28 30 28 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C54">54</xref>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C55">55</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse GCase activity assay (54) and protein detection was described previously (55). The amounts of GCase proteins were quantitated by ImageQuant software relative to the amount of beta-actin in the same sample.
###end p 52
###begin title 53
Tissue GSL analyses
###end title 53
###begin p 54
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C56">56</xref>
###xml 648 649 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 214 218 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
Monohexosylceramides (GC and galactosylceramide), LacCer, GS, lactosylsphingosine (LacSph) and ceramide were quantified by LC/MS in the Lipidomic Core at the Medical University of South Carolina (56). Because C-/- mice had normal levels of saposin A and galactosylceramidase, C-/- and WT mice should have the same levels of galactosylceramide. Consequently, the alterations of monohexosylceramide in the analyses reflect changes in GC. The GSL contents were normalized to phosphate content in the same sample after lipid extraction from tissue lysate. Three animals from each genotype were included in the analyses. Data were analyzed by Student's t-test using GraphPad Prism 5.0 software.
###end p 54
###begin title 55
Behavioral studies
###end title 55
###begin p 56
###xml 94 102 <span type="species:ncbi:9606">Children</span>
The behavioral tests were conducted in the Animal Behavioral Collaborative Core at Cincinnati Children's Research Foundation.
###end p 56
###begin title 57
Narrow bridges
###end title 57
###begin p 58
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C57">57</xref>
###xml 740 741 740 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
###xml 620 624 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
Square beams (1 m) 25, 12 and 5 mm wide and round beams (1 m) with diameters of 28, 17 and 11 mm were used as described (57). The mice were trained by traversing the 12 mm beam for three consecutive days, four trials per day. Animals were considered to be trained when they crossed the 12 mm beam in <20 s. The test phase began on the fourth day. Each mouse in turn received two consecutive trials (up to 60 s/trial) on each square or round beam in a progression from widest to narrowest. Latency to traverse each beam and the number of times the hind foot slipped off the beam were recorded. A total of 26 saposin C-/- mice at 13 months and 17 WT male mice were tested as sex (male) and age-matched groups. Data were analyzed by Student's t-test using GraphPad Prism 5.0 software.
###end p 58
###begin title 59
Tail-hanging reflex observations
###end title 59
###begin p 60
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
Mice were lifted by the tail to observe the leg reflexes every month. The legs of normal mice assume a V position, whereas the affected mice with advanced disease exhibited an abnormal position of the legs and clasped paws. The age at first development of this abnormality was recorded.
###end p 60
###begin title 61
Elevated zero-maze test
###end title 61
###begin p 62
###xml 730 731 730 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 419 423 <span type="species:ncbi:10090">Mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
The apparatus was ring-shaped, and behavior was recorded with an overhead camera connected to a DVD-R. The circular runway was 105 cm in diameter with a 10 cm path width. Two quadrants of the ring were enclosed by black acrylic sidewalls and two quadrants were open; the latter had a 1 cm clear acrylic curb to prevent slipping off the edge. Overhead lights were turned off; a single dim halogen light source was used. Mice were placed in the enclosed quadrant and tested for 5 min. Test sessions were recorded and scored later for time in open area, head dip frequency and number of open area entries. A total of 26 saposin C-/- male mice at 13 months and 17 age-matched WT male mice were tested. Data were analyzed by Student's t-test using GraphPad Prism 5.0 software.
###end p 62
###begin title 63
Locomotor activity
###end title 63
###begin p 64
###xml 139 140 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 497 498 497 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 513 514 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
Locomotor activity was measured in a 41 x 41 x 30 cm Accuscan activity monitor equipped with 16 pairs of photodetector-LED beams along the x and y axes (Accuscan Electronics with VersaMax software, Columbus, OH). The test was conducted under normal overhead fluorescent light. Individual mice were placed in the chambers for 60 min. The apparatus was cleaned with 70% ethanol between animals. Total horizontal distance and vertical activity (rears) were recorded in 5-min intervals. Saposin C-/- (n = 26) and WT (n = 17) male mice were tested at 13 months. Data were analyzed with a mixed model 2-way analysis of variance (Proc GLM, SAS, SAS Institute, Cary, NC) with interval as the repeated measure.
###end p 64
###begin title 65
Electrophysiology
###end title 65
###begin p 66
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DDP531C4">4</xref>
###xml 194 195 190 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 216 217 212 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
Electrophysiology was performed using the MED64 multielectrode array system (Alpha Med Sciences) as described (4). Parasagittal sections (350 microm) were taken from the hippocampus of male WT (n = 7) and C-/- mice (n = 6) at 24 months. Stimulation and recording of resulting fEPSPs were from the Schaffer collateral pathway of the CA1 region of the hippocampus. Slopes of EPSPs following high-frequency stimulation were recorded for 90 min. Brain slices were recorded in duplicate for each animal and the data were averaged per animal. Data were recorded using Performer 2.0 software (Alpha Med Sciences). Data were analyzed using repeated measures ANOVA with gene as a between subject factor and time as a within subject factor, the repeated measure were the fEPSP measurements following LTP induction.
###end p 66
###begin title 67
FUNDING
###end title 67
###begin p 68
###xml 51 54 51 54 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NIH</funding-source>
###xml 54 66 54 66 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C06 PR018823</award-id>
###xml 173 186 173 186 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R01 ES 015689</award-id>
###xml 233 248 233 248 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R01 NS/DK 36681</award-id>
We thank the Lipidomics Core, supported in part by NIHC06 PR018823, at the Medical University of South Carolina. Electrophysiology study was supported by a grant to M.T.W. (R01 ES 015689). This work was supported by grants to G.A.G (R01 NS/DK 36681).
###end p 68
###begin title 69
ACKNOWLEDGEMENTS
###end title 69
###begin p 70
The authors thank Benjamin Liou, Venette Inskeep, Brian Quinn and Juying Xu for their technical assistance; Lisa McMillin, Meredith Farmer, Sabina Sylvest, Georgianne Ciraolo and Chris Woods for skilled tissue preparation and photomicrographs; and Brandy Morris for her clerical expertise.
###end p 70
###begin p 71
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of Interest statement</italic>
Conflict of Interest statement. None declared.
###end p 71
###begin title 72
REFERENCES
###end title 72
###begin article-title 73
Proteolytic processing patterns of prosaposin in insect and mammalian cells
###end article-title 73
###begin article-title 74
Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell
###end article-title 74
###begin article-title 75
Characterization of a nonspecific activator protein for the enzymatic hydrolysis of glycolipids
###end article-title 75
###begin article-title 76
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Neurological deficits and glycosphingolipid accumulation in saposin B deficient mice
###end article-title 76
###begin article-title 77
###xml 56 63 <span type="species:ncbi:9606">patient</span>
Insertion in the mRNA of a metachromatic leukodystrophy patient with sphingolipid activator protein-1 deficiency
###end article-title 77
###begin article-title 78
Acid beta-glucosidase: intrinsic fluorescence and conformational changes induced by phospholipids and saposin C
###end article-title 78
###begin article-title 79
Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation
###end article-title 79
###begin article-title 80
###xml 25 32 <span type="species:ncbi:9606">patient</span>
Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency
###end article-title 80
###begin article-title 81
Neuronopathic juvenile glucosylceramidosis due to sap-C deficiency: clinical course, neuropathology and brain lipid composition in this Gaucher disease variant
###end article-title 81
###begin article-title 82
###xml 34 39 <span type="species:ncbi:9606">human</span>
Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis
###end article-title 82
###begin article-title 83
Molecular and cell biology of acid beta-glucosidase and prosaposin
###end article-title 83
###begin article-title 84
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 39 55 <span type="species:ncbi:562">Escherichia coli</span>
Functional human saposins expressed in Escherichia coli. Evidence for binding and activation properties of saposins C with acid beta-glucosidase
###end article-title 84
###begin article-title 85
Saposins (sap) A and C activate the degradation of galactosylceramide in living cells
###end article-title 85
###begin article-title 86
Stimulation of acid ceramidase activity by saposin D
###end article-title 86
###begin article-title 87
Structural analysis of saposin C and B. Complete localization of disulfide bridges
###end article-title 87
###begin article-title 88
Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C
###end article-title 88
###begin article-title 89
Direct AFM observation of saposin C-induced membrane domains in lipid bilayers: from simple to complex lipid mixtures
###end article-title 89
###begin article-title 90
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human saposins by NMR spectroscopy
###end article-title 90
###begin article-title 91
Phospholipid vesicle fusion induced by saposin C
###end article-title 91
###begin article-title 92
Functional organization of saposin C. Definition of the neurotrophic and acid beta-glucosidase activation regions
###end article-title 92
###begin article-title 93
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Ex vivo localization of the mouse saposin C activation region for acid beta-glucosidase
###end article-title 93
###begin article-title 94
Non-neuronopathic Gaucher disease due to saposin C deficiency
###end article-title 94
###begin article-title 95
###xml 49 55 <span type="species:ncbi:10090">murine</span>
Antigen markers of macrophage differentiation in murine tissues
###end article-title 95
###begin article-title 96
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 106 112 <span type="species:ncbi:10090">murine</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
Turnover and distribution of intravenously administered mannose-terminated human acid beta-glucosidase in murine and human tissues
###end article-title 96
###begin article-title 97
Saposin C: neuronal effect and CNS delivery by liposomes
###end article-title 97
###begin article-title 98
Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids
###end article-title 98
###begin article-title 99
Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo
###end article-title 99
###begin article-title 100
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Combined saposin C and D deficiencies in mice lead to a neuronopathic phenotype, glucosylceramide and alpha-hydroxy ceramide accumulation, and altered prosaposin trafficking
###end article-title 100
###begin article-title 101
A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation
###end article-title 101
###begin article-title 102
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids
###end article-title 102
###begin article-title 103
Consequences of NPC1 and NPC2 loss of function in mammalian neurons
###end article-title 103
###begin article-title 104
Current topics in pharmacological research on bone metabolism: osteoclast differentiation regulated by glycosphingolipids
###end article-title 104
###begin article-title 105
###xml 94 99 <span type="species:ncbi:9606">human</span>
Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells
###end article-title 105
###begin article-title 106
Lactosylceramide: a lipid second messenger in neuroinflammatory disease
###end article-title 106
###begin article-title 107
Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms
###end article-title 107
###begin article-title 108
Cell-autonomous death of cerebellar purkinje neurons with autophagy in Niemann-Pick type C disease
###end article-title 108
###begin article-title 109
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration
###end article-title 109
###begin article-title 110
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse
###end article-title 110
###begin article-title 111
###xml 42 48 <span type="species:ncbi:10090">murine</span>
A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration
###end article-title 111
###begin article-title 112
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
Mutation in the gene encoding lysosomal acid phosphatase (Acp2) causes cerebellum and skin malformation in mouse
###end article-title 112
###begin article-title 113
###xml 53 58 <span type="species:ncbi:10090">mouse</span>
Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration
###end article-title 113
###begin article-title 114
Saposin C-LBPA interaction in late-endosomes/lysosomes
###end article-title 114
###begin article-title 115
###xml 84 91 <span type="species:ncbi:9606">patient</span>
Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: biochemical signs of combined sphingolipidoses
###end article-title 115
###begin article-title 116
Biogenesis of lysosomes in marshall cells and in cells of the male reproductive system
###end article-title 116
###begin article-title 117
Neuroaxonal dystrophy in infantile alpha-N-acetylgalactosaminidase deficiency
###end article-title 117
###begin article-title 118
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Axonal dystrophy of dorsal root ganglion sensory neurons in a mouse model of Niemann-Pick disease type C
###end article-title 118
###begin article-title 119
###xml 82 86 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Mannoside storage and axonal dystrophy in sensory neurones of swainsonine-treated rats: morphogenesis of lesions
###end article-title 119
###begin article-title 120
Neuroaxonal dystrophy in neuronal storage disorders: evidence for major GABAergic neuron involvement
###end article-title 120
###begin article-title 121
Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease
###end article-title 121
###begin article-title 122
Axon degeneration mechanisms: commonality amid diversity
###end article-title 122
###begin article-title 123
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
A mutation in the saposin A domain of the sphingolipid activator protein (prosaposin) gene results in a late-onset, chronic form of globoid cell leukodystrophy in the mouse
###end article-title 123
###begin article-title 124
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line
###end article-title 124
###begin article-title 125
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Gaucher disease mouse models: point mutations at the acid beta-glucosidase locus combined with low-level prosaposin expression lead to disease variants
###end article-title 125
###begin article-title 126
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease
###end article-title 126
###begin article-title 127
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Gaucher disease mouse models: point mutations at the acid {beta}-glucosidase locus combined with low-level prosaposin expression lead to disease variants
###end article-title 127
###begin article-title 128
Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry
###end article-title 128
###begin article-title 129
###xml 115 119 <span type="species:ncbi:10090">mice</span>
Temporal gene expression profiling reveals CEBPD as a candidate regulator of brain disease in prosaposin deficient mice
###end article-title 129

